Compounds > procainamide
Page last updated: 2024-11-03

procainamide and Acquired Autoimmune Hemolytic Anemia

procainamide has been researched along with Acquired Autoimmune Hemolytic Anemia in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kleinman, S1
Nelson, R1
Smith, L1
Goldfinger, D1
Wautier, JL1
Rouger, P1

Reviews

1 review available for procainamide and Acquired Autoimmune Hemolytic Anemia

ArticleYear
[Drug-induced hemolytic anemia].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001, Volume: 8, Issue:4

    Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetab

2001

Other Studies

1 other study available for procainamide and Acquired Autoimmune Hemolytic Anemia

ArticleYear
Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide.
    The New England journal of medicine, 1984, Sep-27, Volume: 311, Issue:13

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Coombs Test; Erythrocytes; Humans; Mal

1984